6 April 2021 — Anthrax Vaccine
Meryl Nass, M.D
The Astra-Zeneca “cheap and easy to store” “workhorse” vaccine causes blood clots in general, and in particular clots in the venous sinuses of the brain, which have killed or wounded a number of people, especially women under 55.
15 February, 2021 — Global Research
16 February 2021– Global Research
By Mark Taliano
Western countries, including Canada, are using experimental mRNA injections in nursing homes, on the most vulnerable of people.
Nobody can give informed consent because the injections are experimental. How do we know that the injections are experimental? There are at least two on-going clinical trials:
16 January 2021 — 21st Century Wire
|
15 January 2021 — NEWS WIRE
As the Government’s bold vaccine roll-out continues, more problems emerge regarding injury and death of people who’ve taken Pfizer’s experimental mRNA genetic COVID ‘vaccine’ – prompting [] China t[o] ban the jab. Meanwhile, the Government makes a power-play to censor media reporting – with the State agency now playing the role editor with major newspapers reporting COVID and lockdown, supposedly in the public interest.’ But what if the press regulator has their facts wrong? The NHS “clap” campaign seems to be bust after UKC sent its team across the country to look for any Thursday night clamour. Also, President Trump’s parting shot [at] the Democratic machine b[y] declassifying all of the FBI Russia probe document. All this and more.
Co-hosts Mike Robinson and Patrick Henningsen take a look at the end of week news round-up. Watch:
25 November 2020 — Michael Roberts
Before the COVID-19 pandemic engulfed the world, the big pharmaceutical companies did little investment in vaccines for global diseases and viruses. It was just not profitable. Of the 18 largest US pharmaceutical companies, 15 had totally abandoned the field. Heart medicines, addictive tranquilizers and treatments for male impotence were profit leaders, not defences against hospital infections, emergent diseases and traditional tropical killers. A universal vaccine for influenza—that is to say, a vaccine that targets the immutable parts of the virus’s surface proteins—has been a possibility for decades, but never deemed profitable enough to be a priority. So, every year, we get vaccines that are only 50% efficient.
